The Patent Finder

1-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- 1- Yl) Ureas as P38 Map Kinase Inhibitors

Respivert Limited

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/GB2012/052445, filed Oct 3, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,108,9501-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- 1- Yl) Ureas as P38 Map Kinase Inhibitors
In force
 · High confidence
Respivert LimitedIn force
High confidence
US 9,850,2311-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors
In force
 · Low confidence
Respivert LimitedIn force
Low confidence
US 10,266,5191-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors
In force
 · Low confidence
Respivert LimitedIn force
Low confidence
US 10,738,0321-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors
In force
 · Low confidence
Respivert LimitedIn force
Low confidence
Application 17/683,8931-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors
Abandoned
Abandoned Feb 7, 2023
Respivert LimitedAbandonedAbandoned Feb 7, 2023
Application 17/937,9321-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors
Abandoned
Abandoned May 23, 2023
Respivert LimitedAbandonedAbandoned May 23, 2023
Application 18/171,5031-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors
Abandoned
Abandoned Nov 28, 2023
Respivert LimitedAbandonedAbandoned Nov 28, 2023
Application 18/355,7101-Pyrazolyl-3- (4- ((2 -Anilinopyrimidin- 4 - Yl) Oxy) Napththalen- I - Yl) Ureas as P38 Mapkinase Inhibitors
Abandoned
Abandoned Sep 11, 2024
Respivert LimitedAbandonedAbandoned Sep 11, 2024
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Respivert Limited.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited